阳光诺和：关联公司晟普医药完成购股计划

Group 1 - The company announced that its senior management personnel, Mr. Li Yuanbo, has actual control over an affiliated enterprise, Sichuan Shengpu Pharmaceutical Technology Center (Limited Partnership) [1] - The affiliated enterprise has cumulatively purchased 612,600 shares of the company's A-shares through centralized bidding, accounting for 0.55% of the company's total share capital [1] - The total amount spent on the share purchase has exceeded 28 million yuan, completing its planned acquisition of company shares [1]